I think MSB needs to reject the recommendation on randomised controlled study on Adults. This BLA application was supposed for under 12 children, not any adult. Why is FDA asking this extra? MSB need to reject it. Otherwise go to the court.
- Forums
- ASX - By Stock
- MSB
- MSB to dispute FDA finding in Type A meeting
MSB to dispute FDA finding in Type A meeting, page-19
-
-
- There are more pages in this discussion • 999 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add MSB (ASX) to my watchlist
(20min delay)
|
|||||
Last
97.0¢ |
Change
0.020(2.11%) |
Mkt cap ! $1.107B |
Open | High | Low | Value | Volume |
94.5¢ | 98.0¢ | 93.5¢ | $3.680M | 3.810M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
5 | 149921 | 96.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
97.5¢ | 60000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
5 | 149921 | 0.965 |
5 | 66704 | 0.960 |
5 | 98366 | 0.955 |
4 | 43570 | 0.950 |
4 | 130698 | 0.945 |
Price($) | Vol. | No. |
---|---|---|
0.975 | 60000 | 1 |
0.980 | 224951 | 2 |
0.985 | 227011 | 7 |
0.990 | 214282 | 8 |
0.995 | 68432 | 3 |
Last trade - 16.10pm 12/08/2024 (20 minute delay) ? |
Featured News
MSB (ASX) Chart |